Association of weight change and in‐hospital mortality in patients with repeated hospitalization for heart failure
Open Access
- 23 December 2022
- journal article
- research article
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 14 (1) , 642-652
Abstract
Background: Although weight loss in heart failure (HF) is a detrimental condition known as cachexia, weight gain caused by fluid retention should also be considered harmful. However, studies with sufficient number of patients examining the impact of weight change and its interval on in‐hospital mortality in HF have not been conducted thus far. We sought to elucidate the association of weight change with in‐hospital mortality in patients with HF.Methods: This retrospective observational study used data from the Diagnosis Procedure Combination database, a nationwide inpatient health claims database in Japan. In total, 48 234 patients repeatedly hospitalized for HF (median 82 [74–87] years; 46.4% men) between 2010 and 2018 were included. Weight change was derived from body weight at the first and second admissions.Results: The median weight change and interval between two hospitalizations were −3.1 [−8.3 to −1.8] % and 172 [67–420] days, with 66.9% of overall cohort experiencing any weight loss. As a result of multivariable‐adjusted logistic regression analysis, weight loss <−5.0% and weight gain >+5.0% were associated with increased in‐hospital mortality (adjusted odds ratio [OR] [95% confidence interval]: 1.46 [1.31–1.62], P < 0.001 and 1.23 [1.08–1.40], P = 0.002, respectively) whereas mild weight loss and gain of 2.0–5.0% were not (OR [95% confidence interval]: 0.96 [0.84–1.10], P = 0.57 and 1.07 [0.92–1.25], P = 0.37, respectively), in comparison with patients with a stable weight (fluctuating no more than −2.0% to +2.0%) used as a reference. Restrictive cubic spline models adjusted for multiple background factors illustrated that higher mortality in patients with weight loss was observed across all subgroups of the baseline body mass index (2). In patients with short (<90 days) and middle (<180 days) intervals between the two hospitalizations, both weight loss and weight gain were associated with high mortality, whereas the association between weight gain and high mortality was attenuated in those with longer intervals.Conclusions: Both weight loss and weight gain in patients with repeated hospitalization for HF were associated with high in‐hospital mortality, especially weight loss and short/middle‐term weight gain. Such patients should be treated with caution in a setting of repeated hospitalization for HF.Keywords
Funding Information
- Ministry of Health, Labour and Welfare (20AA2005, 19AA2007)
- Ministry of Education, Culture, Sports, Science and Technology (20H03907)
This publication has 32 references indexed in Scilit:
- Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the WorldJACC, 2014
- A Tale of Coronary Artery Disease and Myocardial InfarctionNew England Journal of Medicine, 2012
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trialEuropean Heart Journal, 2009
- The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic diseaseEuropean Heart Journal, 2008
- Cachexia: A new definitionClinical Nutrition, 2008
- Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programmeEuropean Heart Journal, 2008
- Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart FailureCirculation, 2007
- Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection FractionNew England Journal of Medicine, 2006
- Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational studyThe Lancet, 2003